291 related articles for article (PubMed ID: 30040746)
1. Usefulness of a flow chart for targeted screening of congenital cytomegalovirus-related hearing loss.
Ciccia M; Monari C; Vitagliano G; Zarro N; Sandri F
J Neonatal Perinatal Med; 2018; 11(3):339-343. PubMed ID: 30040746
[TBL] [Abstract][Full Text] [Related]
2. The Yield of Targeted Examination for the Detection of Symptomatic Congenital Cytomegalovirus Infection.
Masarweh K; Felszer-Fisch C; Shinwell E; Hasanein J; Peniakov M; Weiner SA; Lurye-Marcu B; Miron D
Isr Med Assoc J; 2021 May; 23(5):318-322. PubMed ID: 34024050
[TBL] [Abstract][Full Text] [Related]
3. Effect on hearing of oral valganciclovir for asymptomatic congenital cytomegalovirus infection.
Yilmaz Çiftdogan D; Vardar F
J Trop Pediatr; 2011 Apr; 57(2):132-4. PubMed ID: 20576693
[TBL] [Abstract][Full Text] [Related]
4. Hearing loss in children with congenital cytomegalovirus infection in relation to the maternal trimester in which the maternal primary infection occurred.
Foulon I; Naessens A; Foulon W; Casteels A; Gordts F
Pediatrics; 2008 Dec; 122(6):e1123-7. PubMed ID: 19047212
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus infection during pregnancy: state of the science.
Leruez-Ville M; Foulon I; Pass R; Ville Y
Am J Obstet Gynecol; 2020 Sep; 223(3):330-349. PubMed ID: 32105678
[TBL] [Abstract][Full Text] [Related]
6. [Therapy Options for Infants with Congenital Cytomegalovirus Infection - Implications for Setting Up Neonatal Screening Programs].
Bührer C; Blankenstein O; Rossi R;
Z Geburtshilfe Neonatol; 2020 Apr; 224(2):71-78. PubMed ID: 31426118
[TBL] [Abstract][Full Text] [Related]
7. From diagnosis to management: current perspectives on congenital cytomegalovirus infection.
Buchfellner M; Ross S
Curr Opin Infect Dis; 2024 Aug; 37(4):232-237. PubMed ID: 38748563
[TBL] [Abstract][Full Text] [Related]
8. "Minimally symptomatic" congenital cytomegalovirus infection: latest data and emerging concepts.
Howard A; Nishikawa JK; Sánchez PJ
Curr Opin Pediatr; 2024 Aug; 36(4):480-488. PubMed ID: 38747205
[TBL] [Abstract][Full Text] [Related]
9. Valganciclovir Is Beneficial in Children with Congenital Cytomegalovirus and Isolated Hearing Loss.
Pasternak Y; Ziv L; Attias J; Amir J; Bilavsky E
J Pediatr; 2018 Aug; 199():166-170. PubMed ID: 29605391
[TBL] [Abstract][Full Text] [Related]
10. Oral Valganciclovir treatment in a CMV congenital infected infant with sensorineural hearing loss (SNHL) first detected at 4 months of age.
Hilgendorff A; Daiminger A; Dangel V; Kreuder J; Geidel C; Reiss I; Enders G
Klin Padiatr; 2009 Dec; 221(7):448-9. PubMed ID: 20013570
[No Abstract] [Full Text] [Related]
11. Contribution of targeted saliva screening for congenital CMV-related hearing loss in newborns who fail hearing screening.
Ari-Even Roth D; Lubin D; Kuint J; Teperberg-Oikawa M; Mendelson E; Strauss T; Barkai G
Arch Dis Child Fetal Neonatal Ed; 2017 Nov; 102(6):F519-F524. PubMed ID: 28468898
[TBL] [Abstract][Full Text] [Related]
12. Viral load in children with congenital cytomegalovirus infection identified on newborn hearing screening.
Kawada J; Torii Y; Kawano Y; Suzuki M; Kamiya Y; Kotani T; Kikkawa F; Kimura H; Ito Y
J Clin Virol; 2015 Apr; 65():41-5. PubMed ID: 25766986
[TBL] [Abstract][Full Text] [Related]
13. Universal neonatal cytomegalovirus screening using saliva - report of clinical experience.
Barkai G; Ari-Even Roth D; Barzilai A; Tepperberg-Oikawa M; Mendelson E; Hildesheimer M; Kuint J
J Clin Virol; 2014 Aug; 60(4):361-6. PubMed ID: 24881490
[TBL] [Abstract][Full Text] [Related]
14. Isolated auditory neuropathy at birth in congenital cytomegalovirus infection.
Natale F; De Curtis M; Bizzarri B; Orlando MP; Ralli M; Liuzzi G; Caravale B; Franco F; Gaeta A; Giancotti A; Russo FY; Turchetta R
Ital J Pediatr; 2020 Jan; 46(1):3. PubMed ID: 31906974
[TBL] [Abstract][Full Text] [Related]
15. [Congenital CMV infections].
Wieringa JW; de Vries JJ; Murk JL
Ned Tijdschr Geneeskd; 2013; 157(41):A6250. PubMed ID: 24103134
[TBL] [Abstract][Full Text] [Related]
16. Congenital Cytomegalovirus Infection.
Kabani N; Ross SA
J Infect Dis; 2020 Mar; 221(Suppl 1):S9-S14. PubMed ID: 32134480
[TBL] [Abstract][Full Text] [Related]
17. Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up.
Lackner A; Acham A; Alborno T; Moser M; Engele H; Raggam RB; Halwachs-Baumann G; Kapitan M; Walch C
J Laryngol Otol; 2009 Apr; 123(4):391-6. PubMed ID: 18588736
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Valganciclovir Treatment Depends on the Severity of Hearing Dysfunction in Symptomatic Infants with Congenital Cytomegalovirus Infection.
Ohyama S; Morioka I; Fukushima S; Yamana K; Nishida K; Iwatani S; Fujioka K; Matsumoto H; Imanishi T; Nakamachi Y; Deguchi M; Tanimura K; Iijima K; Yamada H
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30893926
[TBL] [Abstract][Full Text] [Related]
19. Encouraging postnatal cytomegalovirus (CMV) screening: the time is NOW for universal screening!
Ronchi A; Shimamura M; Malhotra PS; Sánchez PJ
Expert Rev Anti Infect Ther; 2017 May; 15(5):417-419. PubMed ID: 28277819
[No Abstract] [Full Text] [Related]
20. Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss.
Williams EJ; Kadambari S; Berrington JE; Luck S; Atkinson C; Walter S; Embleton ND; James P; Griffiths P; Davis A; Sharland M; Clark JE
Arch Dis Child Fetal Neonatal Ed; 2014 May; 99(3):F230-6. PubMed ID: 24596404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
